| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/17/2004 | US6693075 Factor viia polypeptide comprising modified carboxyglutamic acid domain; enhancing membrane binding affinity and activity |
| 02/17/2004 | US6692950 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
| 02/17/2004 | US6692949 Having amino acid sequence comprising id 2 |
| 02/17/2004 | US6692948 Isolated human kinase proteins |
| 02/17/2004 | US6692947 Structural similarity with animal beta 1,4 n-acetylgalac-tosamine transferases |
| 02/17/2004 | US6692946 Polynucleotides encoding the nadA gene and methods of producing nicotinic acid or nicotinic acid derivatives |
| 02/17/2004 | US6692940 Utilizing nucleotides 1 to 3060 of sequence number 3 or subsequence thereof |
| 02/17/2004 | US6692936 Novel polypeptide belonging to the class of proteins known as g-protein coupled receptors |
| 02/17/2004 | US6692932 Thermostable DNA polymerase from anaerocellum thermophilum |
| 02/17/2004 | US6692917 Systems and methods for invasive cleavage reaction on dendrimers |
| 02/17/2004 | CA2183755C Pharmaceutical preparation containing plasminogen activators |
| 02/16/2004 | CA2437478A1 Brassica pdhk gene |
| 02/12/2004 | WO2004013347A2 Methods of identifying compounds that modulate protein activity |
| 02/12/2004 | WO2004013345A1 Method for the biotransformation of carotenoids by means of a cytochrome p450 monooxygnase |
| 02/12/2004 | WO2004013343A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 02/12/2004 | WO2004013333A2 Inversion of the negative-selective effect of negative marker proteins using selection methods |
| 02/12/2004 | WO2004013332A1 Substrate conversion |
| 02/12/2004 | WO2004013327A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | WO2004013324A1 Novel crystalline tryptase and utilization thereof |
| 02/12/2004 | WO2004013323A1 Sequence of a putative humain serine protease |
| 02/12/2004 | WO2004013322A2 Degrading lignocellulosic materials |
| 02/12/2004 | WO2004013321A1 Esterase esta (xc4a) of xanthomonas vesicatoria |
| 02/12/2004 | WO2004013320A1 Regulation of human methyltransferase |
| 02/12/2004 | WO2004013319A2 Regulation of human esterase |
| 02/12/2004 | WO2004013314A1 CELLS, WHICH SECRETE R-α-LIPOIC ACID AND METHOD FOR PRODUCING SAID R-α-LIPOIC ACID BY FERMENTATION |
| 02/12/2004 | WO2004013312A2 Tocopherol biosynthesis related genes and uses thereof |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013283A2 Thioredoxin mutants and uses thereof |
| 02/12/2004 | WO2004013167A2 Purified polypeptides from enterococcus faecalis |
| 02/12/2004 | WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | WO2004013159A2 RECOMBINANT BIOTIN CARBOXYLASE DOMAINS FOR IDENTIFICATION OF ACETYL CoA CARBOXYLASE INHIBITORS |
| 02/12/2004 | WO2004013152A2 Novel targets for lithium therapy |
| 02/12/2004 | WO2004013092A2 Beta-alanine n-methyltransferase |
| 02/12/2004 | WO2004012817A2 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs |
| 02/12/2004 | WO2004012732A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 02/12/2004 | WO2004012683A2 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | WO2003102152A3 Methods and materials for the production of lactic acid in yeast |
| 02/12/2004 | WO2003095636A3 Activation induced deaminase (aid) |
| 02/12/2004 | WO2003093232A3 Feline pancreatic lipase composition and method of preparing and using such composition |
| 02/12/2004 | WO2003089456A3 Peptide inhibitors of protein kinase c |
| 02/12/2004 | WO2003083054A8 Amylases, nucleic acids encoding them and methods for making and using them |
| 02/12/2004 | WO2003080802A3 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 02/12/2004 | WO2003079766A3 Generation of plants with altered oil content |
| 02/12/2004 | WO2003078639A3 Transgenic plants expressing enzymes involved in fatty acid biosynthesis |
| 02/12/2004 | WO2003076582A3 A novel protein kinase induced during sporangial cleavage in the oomycete phytophthora infestans |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003027238A3 Stabilization of t4 endonuclease v |
| 02/12/2004 | WO2003027227A3 Usp-3like deubiquitinating enzyme gene disruptions, compositions and methods related thereto |
| 02/12/2004 | WO2003018776A3 IDENTIFICATION OF THE IκBNS PROTEIN AND ITS PRODUCTS |
| 02/12/2004 | WO2003014324A3 Thermostable uvra and uvrb polipeptides and methods of use |
| 02/12/2004 | WO2003008587A3 A lactococcus gene, the amylolytic enzyme it encodes and its application |
| 02/12/2004 | WO2003000897A8 Identification and characterization of phosphate transporter genes |
| 02/12/2004 | WO2002097082A3 Engineered biosynthesis of novel polyenes |
| 02/12/2004 | WO2002068616A8 Tissue transglutaminase |
| 02/12/2004 | WO2002059333A3 Gene promoters isolated from potato and use thereof |
| 02/12/2004 | WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution |
| 02/12/2004 | WO2002046390A3 Transgenic mice containing rptpb tyrosine phosphatase gene disruptions |
| 02/12/2004 | WO2002045495A3 Transgenic mice containing targeted gene disruptions |
| 02/12/2004 | WO2002040686A3 Expression system for recombinant proteins |
| 02/12/2004 | US20040031074 Isolated from tobacco, recombinant nucleic acids containing the same, expression vectors and transgenic plants produced therewith |
| 02/12/2004 | US20040031073 Method for modifying plant morphology, biochemistry and physiology |
| 02/12/2004 | US20040030117 Attenuating mutations and methods of making them, the alphavirus vector delivers the heterologous nucleotide sequence to the cells of the bone, bone marrow, and/or bone-associated connective tissue |
| 02/12/2004 | US20040030116 Used in identification of microorganisms which can be used to produce fine chemicals, the modulation of fine chemical production in C. glutamicum or related bacteria, the typing or identification of C. glutamicum as transformation markers |
| 02/12/2004 | US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents |
| 02/12/2004 | US20040030110 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029792 Isolation nucleic acids; determination, measurement, calibration; genetic engineering |
| 02/12/2004 | US20040029756 Granule with hydrated barrier material |
| 02/12/2004 | US20040029283 Intron double stranded RNA constructs and uses thereof |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029278 Recombinant alphaviruses which are capable of expressing a heterologous sequence in target cells |
| 02/12/2004 | US20040029256 Genetically modified Kluyveromyces cells, methods for making them, and their use in production of organic products, particularly D-lactic acid |
| 02/12/2004 | US20040029252 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 02/12/2004 | US20040029249 Proteases |
| 02/12/2004 | US20040029247 Regulation of human adenylate cyclase, type iv |
| 02/12/2004 | US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/12/2004 | US20040029245 Used in preventing, ameliorating, or correcting dysfunctions or diseases including cancer, diabetes, and obesity |
| 02/12/2004 | US20040029243 A detoxification/ decontamination system for nerve agents which has long term stability over a wide temperature range |
| 02/12/2004 | US20040029239 comprising creating a recombinant obtained by transferring into a host a recombinant DNA for expression or a DNA fragment for genomic integration |
| 02/12/2004 | US20040029234 Enhanced 2-keto-l-gulonic acid production |
| 02/12/2004 | US20040029231 Mutant E.coli strains, and their use for producing recombinant polypeptides |
| 02/12/2004 | US20040029230 DNA strands useful for the production of parahydroxycinnamic acid and photoactive yellow protein in a suitable host expression system |
| 02/12/2004 | US20040029225 Lipoxygenase |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029220 Novel proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029204 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029173 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 02/12/2004 | US20040029167 Inducible COMT_II promoter, chimeric gene containing same and plants transformed therewith |
| 02/12/2004 | US20040029157 A DNA containing a nucleotide sequence encoding the amino acid sequence with partial substitution, deletion or addition and having cell cycle control activity; for controlling abnormal cell growth like cancer |
| 02/12/2004 | US20040029136 Diagnosing, treating, or preventing disorders associated with aberrant expression of lipid metabolism molecules (LMM) |
| 02/12/2004 | US20040029134 P53-associated Parkin-like cytoplasmic protein, and related compositions and methods |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029125 Diagnosis, therapy, prevention autoimmune diseases; genetic engineering; culture product; reducing gene expression |
| 02/12/2004 | US20040029107 DNA sequence coding for bacteriophage recombinase; ligand-binding domain of steroid receptors; vectors |
| 02/12/2004 | US20040028775 Soaking in water; grinding; using protease enzyme |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028683 Modulators of p85 expression |
| 02/12/2004 | US20040028671 Ginsenoside glycosidases hydrolyzing ginsenoside sugar moieties and uses thereof |